Why BridgeBio Stopped Galactosemia Gene Therapy
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Why BridgeBio Stopped Galactosemia Gene Therapy
-
Narrated by:
-
Written by:
About this listen
BridgeBio recently stopped their research and development of gene therapy for Galactosemia. This came as a shock to many of us. I talked to the CEO of BridgeBio on the phone, and in this episode I report back what he told me.
No reviews yet